HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Global Medical Robotics Market to Reach USD 20 Billion by 2022

By HospiMedica International staff writers
Posted on 20 Sep 2017
The global medical robotics market is expected to grow at a CAGR of 21.6%from USD 6.36 billion in 2016 to USD 20.56 billion by 2022, driven by the enhancement of automation technologies, rising incidence of disabilities in human beings and growing baby boomer population, that impede their day-to-day physical motions.

These are the latest findings of Research and Markets (Dublin, Ireland), a global market research company.
Medical robots are used by surgeons to gain greater access to areas under operation using more detailed and less invasive methods. They are present in most telemanipulators, which use the surgeon's actions on one side and to control the "effector" on the other side.

Currently, the demand for medical robots is driven by the rapidly growing demand for precise and efficient minimally invasive surgeries, although the high cost of surgery, negative publicity, and wariness among people continue to pose a challenge to the market growth. The neurology segment is expected to register the fastest growth in the medical robots market during the forecast period, driven by the advent of newer applications in neurosurgery and the growing popularity of robotic neurosurgery.

In 2016, North America held the highest share of the global medical robotics market, due to the high adoption rate of medical robots in the region and the government's strong focus on medical robots to improve the quality of healthcare. The medical robotic systems market in Asia Pacific is expected to grow at the fastest rate during the forecast period due to the availability of untapped market opportunities.

Related Links:
Research and Markets

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Surgical Headlight
IsoTorch

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more